Clinical Trials Directory

Trials / Completed

CompletedNCT02622373

Impact of Currently Recommended Postnatal Nutrition on Neonatal Body Composition

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Vishal Pandey, M.D. · Academic / Other
Sex
All
Age
23 Weeks – 42 Weeks
Healthy volunteers
Accepted

Summary

The purpose of this study is to gain information that may be useful in helping to figure out better or newer ways to provide nutrition to babies born premature.

Detailed description

Babies born premature weigh significantly less at the time of hospital discharge when compared to babies born at the corresponding age. The researchers in this study believe that the lower body weight at discharge may be due to lower muscle mass. However, there is no such information available for that at this time. It is important to have this information as babies who weigh less than normal at hospital discharge may develop higher blood pressure and higher sugar levels when they are 10-15 years old. By doing this study, researchers will be able to have information about the baby's muscle mass, which will help the researchers to provide better nutrition to babies who are born premature. Researchers will also be able to determine if there are any differences in the muscle/fat mass based on the type of feeding (breast milk alone, formula alone or a combination of breast milk and formula). This information may be beneficial in helping to promote the appropriate type of feeding for babies born premature.

Conditions

Interventions

TypeNameDescription
DEVICEPEA POD Infant Body Composition SystemThe non-invasive device used in this study to measure a baby's body composition is a called a Pea Pod. The Pea Pod is a quick, safe, non-invasive and reliable bedside procedure used to measure changes in infant body composition.

Timeline

Start date
2015-06-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2015-12-04
Last updated
2016-07-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02622373. Inclusion in this directory is not an endorsement.